人类细胞系与癌症治疗 - Suppr | 超能文献

Human cells lines and treatment of cancer.

出版信息

In Vitro. 1978 Sep;14(9):733.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Human cells lines and treatment of cancer.人类细胞系与癌症治疗

In Vitro. 1978 Sep;14(9):733.

2

Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.通过TCRαβ基因转移将人CD4 + T淋巴细胞重定向至MHC I类限制性黑色素瘤抗原MAGE-A1需要CD8α。

Gene Ther. 2005 Jan;12(2):140-6. doi: 10.1038/sj.gt.3302388.

3

Differential metabolism of thymidine in human lymphoid and melanoma cells in vitro.人淋巴细胞和黑色素瘤细胞在体外对胸苷的差异代谢

Anticancer Res. 1984 May-Jun;4(3):173-8.

4

Lysis by activated lymphocytes of melanoma and small cell lung cancer cells surviving in vitro treatment with mafosfamide.用马磷酰胺体外处理后存活的黑色素瘤和小细胞肺癌细胞被活化淋巴细胞裂解。

Cancer Res. 1987 May 15;47(10):2547-52.

5

Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines.

Cancer Res. 1987 Dec 1;47(23):6243-7.

6

The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines.热疗和美法仑对人成纤维细胞株和黑色素瘤细胞系存活率的影响。

Cancer Res. 1977 Jan;37(1):152-6.

7

Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.抗原特异性肿瘤疫苗。编码MART1或gp100的重组腺病毒用于癌症治疗的研发与特性分析。

J Immunol. 1996 Jan 15;156(2):700-10.

8

Development of a human monoclonal antibody to ganglioside G(M2) with potential for cancer treatment.开发一种对神经节苷脂G（M2）具有癌症治疗潜力的人源单克隆抗体。

Cancer Res. 1996 Dec 15;56(24):5666-71.

9

Differential segregation patterns of human chromosomes in somatic cell hybrids constructed with human B-lymphocytes and human melanoma cells.用人B淋巴细胞和人黑色素瘤细胞构建的体细胞杂种中人类染色体的差异分离模式。

Cancer Res. 1982 Oct;42(10):3971-3.

10

Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.小鼠抗独特型单克隆抗体MK2-23模拟人高分子量黑色素瘤相关抗原：对恶性黑色素瘤患者免疫原性的调节

Clin Cancer Res. 1995 Jul;1(7):705-13.

本文引用的文献

1

Cancer immunity--hypothesis and clinical trial of lymphocytotherapy for malignant diseases.癌症免疫——恶性疾病淋巴细胞疗法的假说与临床试验

Ann Surg. 1970 Oct;172(4):733-9. doi: 10.1097/00000658-197010000-00017.

2

Auto-inoculation of cultured human lymphocytes in malignant melanoma.恶性黑色素瘤中培养的人淋巴细胞的自体接种

N Y State J Med. 1969 Feb 1;69(3):460-2.

3

The life span of the cultured normal cell: concepts derived from studies of human lymphoblasts.培养的正常细胞的寿命：源自人类淋巴母细胞研究的概念。

J Theor Biol. 1968 Aug;20(2):217-26. doi: 10.1016/0022-5193(68)90191-4.

4

Perspective of human cell culture.人类细胞培养的视角。

Surg Clin North Am. 1967 Dec;47(6):1315-24. doi: 10.1016/s0039-6109(16)38380-3.